慢性副甲状腺症患者の腎機能低下に関連する要因

Elena López-Mezquita Torres¹, Antonia García-Martín^1,2,3, María Del Carmen Andreo-López^1,2

¹Endocrinology and Nutrition Unit, University Hospital Clínico San Cecilio, 18016 Granada, Spain.

Journal of clinical medicine

|August 28, 2025

まとめ

慢性副甲状腺症の持続期間は腎臓機能不全を予測します心血管疾患の要因は,これらの患者で腎臓の損傷を悪化させる可能性があります.

科学分野:

腎臓科
内分泌学
心臓病科

背景:

慢性副甲状腺症の患者は腎臓合併症や心血管疾患 (CVD) のリスクが高くなります.
この集団における腎機能に影響を与える要因を理解することは,リスクの階層化と管理に不可欠です.

研究の目的:

慢性副甲状腺症の患者における疾患の持続時間,心血管系因子,および腎機能の関係を調査する.
このコホートにおける慢性腎疾患 (CKD) の予測要因を特定する.

主な方法:

慢性副甲状腺症と診断された100人の患者を対象とした遡及的研究.
推定のグルメルフィルタレーション率 (eGFR) の動向と,疾患の持続時間,尿路石症,高血圧,2型糖尿病,脂質不全症を含む臨床的要因との関連分析
ロジスティック回帰とROC曲線解析を用いて,CKDの予測値を評価した.

主要な成果:

eGFRの有意な低下が観察され,疾患の持続時間と強く関連した (p < 0. 001).
EGFRの低下は,疾患の持続時間,尿路石病,高血圧,第2型糖尿病,および脂質不全と関連していた.
14% の患者がCKDを発症し,疾患の持続時間 (p < 0. 001) が有意な予測因子であった (OR = 1. 11; 95% CI [1. 03-1.22]). 持続期間は15. 5年であり,CKDの診断には85. 7%の感度と71. 9%の特異性が示された (AUC=0. 850).

結論:

慢性性副甲状腺症の腎機能障害の有意な予測要因は,疾患の持続時間である.
心血管疾患の危険因子の存在は,これらの患者の腎臓損傷を悪化させる.
病期が長くなった場合,腎臓の合併症を注意深く観察する必要があります.

キーワード:

心血管疾患慢性的な甲状腺機能低下慢性腎臓疾患パラホルモン類

さらに関連する動画

05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

838

07:13

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation

Published on: March 14, 2017

14.7K

関連する概念動画

01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...

01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

01:27

Dialysis

473

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...

473

01:11

Renal Failure: Dose Adjustments

152

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

152

00:59

The Parathyroid Glands

2.5K

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...